Two cases of rifampin desensitization in AIDS patients with rifampin hypersensitivity.
- Author:
Hye Sun SEO
1
;
Pil Ki MIN
;
Cheol Woo KIM
;
Jung Won PARK
;
Jae Hee JEONG
;
Kyung Hee JANG
;
Jun Myung KIM
;
Chein Soo HONG
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. haesunfree@yonsei.md
- Publication Type:Case Report
- Keywords:
AIDS;
rifampin hypersensitivity;
desensitization
- MeSH:
HIV;
HIV Infections;
Humans;
Hypersensitivity*;
Pneumonia, Pneumocystis;
Rifampin*;
Trimethoprim, Sulfamethoxazole Drug Combination;
Tuberculosis, Pulmonary
- From:Journal of Asthma, Allergy and Clinical Immunology
2002;22(1):119-123
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Adverse reactions to drugs are more common in HIV infected patients. Hypersensitivity to trimethoprim-sulfamethoxazole (TMP/SMZ) during treatment or prophylaxis of Pneumocystis carinii pneumonia (PCP) is the most frequent drug reaction of HIV infection. Although less extensively documented than sulphonamides, other drugs also seem to induce drug reactions in HIV-seropositive patients more than in other groups. Rifampin is an essential anti-tuberculosis medication; thus, desensitization of rifampin is especially necessary in our country in which mycobacterial infection is common. We report two cases of AIDS patients with pulmonary tuberculosis who have rifampin hypersensitivity whose rifampin treatment will end successfully through rifampin desensitization.
